Abstract
There are no definitive curative or preventative therapies available for Meniere’s disease. Treatment modalities are based on several theories surrounding the possible causes of the disease, and treatment aims to reduce symptoms of vertigo and preserve hearing and balance function. Here, we describe medical management strategies of Meniere’s disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A. Diagnostic criteria for Menière’s disease. J Vestib Res. 2015;25(1):1–7.
Palaskas C, Dobie R, Snyder J. Progression of hearing loss in bilateral Meniere’s disease. Laryngoscope. 1988;98:287–90.
Foster CA, Breeze RE. Endolymphatic hydrops in Ménière’s disease: cause, consequence, or epiphenomenon? Otol Neurotol. 2013;34(7):1210–4.
Nevoux J, Franco-Vidal V, Bouccara D, Parietti-Winkler C, Uziel A, Chays A, Dubernard X, Couloigner V, Darrouzet V, Mom T, Groupe de Travail de la SFORL. Diagnostic and therapeutic strategy in Menière’s disease. Guidelines of the French Otorhinolaryngology-Head and Neck Surgery Society (SFORL). Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(6):441–4.
Furstenberg A, Lashmet F, Lathrop F. Meniere’s symptom complex: medical treatment. Ann Otol Rhinol Laryngol. 1934;43:1035–46.
Fustenberg A, Richardson G, Lathrop F. Meniere’s disease. Arch Otolaryngol Head Neck Surg. 1941;34:1083–92.
Boles R, Rice D, Hybels R, Work W. Conservative management of Meniere’s disease: Furstenberg regimen revisited. Ann Otol Rhinol Laryngol. 1975;84:513–7.
Klockhoff I, Lindblom U. Meniere’s disease and hydrochlorothiazide- a critical analysis of symptoms and therapeutic effects. Acta Otolaryngol. 1967;63:347–65.
Corvera J, Corvera G. Long-term effect of acetazolamide and chlorthalidone on the hearing loss of Meniere’s disease. Am J Otol. 1989;10:142–5.
Crowson MG, Patki A, Tucci DL. A systematic review of diuretics in the medical management of Meniere’s disease. Otolaryngol Head Neck Surg. 2016;154(5):824–34.
Thirlwall AS, Kundu S. Diuretics for Ménière’s disease or syndrome. Cochrane Database Syst Rev. 2006;3:CD003599.
James A, Burton MJ. Betahistine for Ménière’s disease or syndrome. Cochrane Database Syst Rev. 2001;1:CD001873.
Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M, BEMED Study Group. Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016;21:352.
Neff BA, Staab JP, Eggers SD, Carlson ML, Schmitt WR, Van Abel KM, Worthington DK, Beatty CW, Driscoll CL, Shepard NT. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Ménière’s disease, vestibular migraine, and Ménière’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33(7):1235–44.
Radtke A, Lempert T, Gresty MA, Brookes GB, Bronstein AM, Neuhauser H. Migraine and Ménière’s disease: is there a link? Neurology. 2002;59(11):1700–4.
Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012;52(6):930–45.
Duke WW. Meniere’s syndrome caused by allergy. JAMA. 1923;81(26):2179–81.
Viscomi GJ, Bojrab DI. Use of electrocochleography to monitor antigenic challenge in Meniere’s disease. Otolaryngol Head Neck Surg. 1992;107(6):733–7.
Powers WH. Allergic factors in Meniere’s disease. Trans Am Acad Opthalmol Otolaryngol. 1973;77:22–9.
Shaver EF Jr. Allergic management of Meniere’s disease. Arch Otolaryngol. 1975;101(2):96–9.
Derebery MJ. Allergic management of Meniere’s disease: an outcome study. Otolaryngol Head Neck Surg. 2000;122(2):174–82.
Dereberry MJ, Berliner KI. Prevalence of allergy in Meniere’s disease. Otolaryngol Head Neck Surg. 2000;123:69–75.
Keles E, Godekmerdan A, Kalidag T, Kaygusuz I, Yalcin S, Cengiz AH, Aral M. Meniere’s disease and allergy: allergens and cytokines. J Laryngol Otol. 2004;118(9):688–93.
Hillier SL, McDonnell M. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2011;2:CD005397.
van Esch BF, van der Scheer-Horst ES, van der Zaag-Loonen HJ, Bruintjes TD, van Benthem PP. The effect of vestibular rehabilitation in patients with Ménière’s disease. Otolaryngol Head Neck Surg. 2017 Mar;156(3):426–34.
Hall CD, Herdman SJ, Whitney SL, Cass SP, Clendaniel RA, Fife T, Furman JM, Goebel J, Shepard NA, Woodhouse S. Vestibular rehabilitation for peripheral vestibular hypofunction: clinical practice guidelines. J Neurol Phys Ther. 2016;40:124.
Arif M, Sadlier M, Rajenderkumar D, James J, Tahir T. A randomised controlled study of mindfulness meditation versus relaxation therapy in the management of tinnitus. J Laryngol Otol. 2017;131(6):501–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cass, S.P., Machala, M.C., Ambrose, E.C. (2019). Medical Management of Meniere’s Disease. In: Babu, S., Schutt, C., Bojrab, D. (eds) Diagnosis and Treatment of Vestibular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-97858-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-97858-1_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-97857-4
Online ISBN: 978-3-319-97858-1
eBook Packages: MedicineMedicine (R0)